A patent dispute over a potentially lifesaving artificial heart valve is prompting a scramble among doctors and hospitals to treat desperately ill elderly patients before a court injunction curtails sale of one of the devices Tuesday.. Late last week, a federal judge issued an injunction barring Medtronic Inc. from selling its new, minimally invasive heart implant in the U.S. The decision followed a 2010 jury verdict that the device infringed a patent held by Medtronic's chief competitor, Edwards Lifesciences Corp.